In human medulloblastoma, patients with high expression of PD-L1 and low infiltration of CD8+ lymphocytes had a significantly worse outcome, with a 5-year survival rate of 15%, as compared with the other patients, who had a 5-year survival rate of nearly 90% [36]. This evidence concerns the gene CD274 and medulloblastoma.